What's wrong with sleep-training your baby?

Bouncing up and down on a ball. Playing heavy metal music. Sleeping in the bedroom doorway. These are some of the desperate lengths parents resort to in order to get their children to sleep at bedtime. It sounds mad. Yet none of this will come as a surprise to parents with young children. My own four-year-old only drifts off to sleep if we both become cats for the final few minutes of bedtime. I am then obliged to say good night to him in 'cat': 'Miaow, miaow-miaow' – in case you were wondering. Still, once this is done, he does then fall asleep on his own, in his own bed, and only wakes in the night if he has a nightmare or is ill.
Sleep training is the final taboo for parents
I must be one of the lucky ones, because a survey of 3,000 mums and dads, carried out by Survation for CBeebies Parenting, suggests that 40 per cent of parents are 'sleep starved', getting by on just three to five hours of sleep a night. Two-thirds said their child's sleep pattern disrupted their own sleep.
The most glaring finding was that less than 40 per cent of parents followed a consistent bedtime routine. But we shouldn't really be surprised, because in the UK practical baby-care advice is not readily provided to expectant parents. I do not remember at any point in either of my pregnancies anyone mentioning the importance of routine for babies.
During my first pregnancy, my husband and I joined a National Childbirth Trust (NCT) course to help us prepare. All I can recall is a traumatically graphic description of a caesarean and my introduction to the term 'skin-on-skin'. Everyone was very excited about this, but two babies later, I still think it is massively overrated; as long as you can hold your baby, who cares what you are, or aren't, wearing?
The importance of routine, however, I discovered much later, around five months into being a new mother. It was a winter's evening, it was snowing, and despite being massively sleep-deprived, I was outside trudging through the slushy streets. Why? Because pushing my baby in his pram was the only way he would sleep. Thanks to a supportive phone call from another mum, and her recommendation of an app that focused on daily routines, I finally began to understand why my son refused to go to bed before midnight: if you let a baby take a three-hour nap until 5 p.m., he will not be tired for bedtime at 7 p.m.
So transformational was this app's month-by-month daily schedules, complete with naptimes, feeding suggestions and 'wake windows' (the amount of time a baby should stay awake between naps), that when I had my second baby, while still in the labour ward and less than 24 hours after giving birth, I was Googling: 'How soon can you get a newborn baby onto a routine?'
It seems obvious now, but in the newborn trenches it's hard to work such things out on your own; you need to be given this information. Understandably, midwives focus on the health of your pregnancy and prepare you for childbirth. But would it be so out of the question to expect a few baby-care pointers, like how many naps a day your baby should be doing in the first few months?
Sleep training is the final taboo for parents, but after doing my research, I concluded that the controlled crying method was not harmful, and would most likely be beneficial to all of us. So, when my son was six months old, we tried it out. It was not a fun week, but it was successful. From then on, bar a few occasions, he fell asleep independently and slept through the night. It was a revelation.
Keen to share my triumph with my fellow mums, I put something in my NCT WhatsApp group. Despite our collective obsession with baby sleep being a daily topic of discussion, my message was met with radio silence. Later, one of the dads in the group privately messaged my husband to ask him how he had convinced me to try out sleep training.
The NCT website dares to broach the subject, but makes it clear it is not enthusiastic about the idea:
'The research on sleep training in the first six months of life is contradictory. One review suggested it can work for most young children but a more recent review found that sleep training does not improve outcomes for mums or babies.'
This seems misleading. New parents are much better advised to consult economist and parenting author Emily Oster. In her book, Cribsheet, she provides detail on the significant amount of data on sleep training studies available, allowing parents to make their own informed choices.
While I'm not trying to push sleep training onto anyone, I do think it strange that the very idea of teaching your child to sleep independently has become so controversial. We expect parents to teach their children how to eat with cutlery and how to dress themselves, yet the idea that we might also impart this essential skill of independent sleep is treated very differently. Perhaps parents would fare better – and sleep more – if we began having honest conversations about the practical side of caring for a baby before a mewling newborn is placed into the arms of its bewildered new mother.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Daily Record

32 minutes ago

• Daily Record

Men in their 20s and 30s urged to check for early cancer signs after a shower

A recent survey says many adults are unaware of the fact that the cancer is most prevalent among younger men Conducting a swift examination after your shower could be crucial in protecting against a cancer that's alarmingly common among men in their 20s and 30s. The step could lead to the early detection of a condition that impacts thousands in the UK annually. A recent study has highlighted a worrying lack of knowledge about the prevalence of testicular cancer in younger men. In the US, for instance, research by The Ohio State University Comprehensive Cancer Centre revealed that only 13 per cent of adults in America were able to correctly identify testicular cancer as a condition primarily affecting men under 40. ‌ Shawn Dason, a urologic oncologist at the centre, noted that this type of cancer is most frequently diagnosed in men between 20 and 40 years old. He said: "In my experience, a lot of men are surprised that testicular cancer is most common among young men. ‌ "It's something you're just not expecting in your twenties or thirties. A lot of young men's focus might be on developing their career, their day-to-day life. That's a very different track of mind than perhaps your health." From the 1,008 individuals surveyed, 63 per cent correctly believed that testicular cancer is often curable if caught early, while just over half, at 54 per cent, recognised the significance of monthly self-checks, reports Surrey Live. Mr Dason said: "We are really fortunate in testicular cancer that the vast majority of patients are diagnosed at an early stage. "That means the vast majority of patients are actually diagnosed before the cancer has had an opportunity to spread to other parts of the body." He added: Testicular cancer does not typically come with painful symptoms. That's why routine self-exams are so important to detect any lumps or changes to the testicle. If you feel something out of the ordinary, like a lump or bump, or if the testicle changes in size, call your doctor." Carrying out a self-examination Cancer Research UK advises that occasionally checking and feeling your testicles can be useful, and many find it simpler during or after a warm bath or shower. You should assess your testicles for their size and weight, and look for any unusual lumps or swellings. In case you observe any of the following signs, getting in touch with your GP is advised: The charity said: "Your symptoms are unlikely to be cancer but it's important to get them checked by a doctor."

Rhyl Journal

34 minutes ago

• Rhyl Journal

Rantzen warns peers not to hamper progress of assisted dying law

The Terminally Ill Adults (End Of Life) Bill cleared the Commons with a majority of 23 votes on Friday, but opponents have vowed to continue their resistance in the unelected chamber. The legislation could face a difficult passage through the Lords, with critics poised to table amendments to add further restrictions and safeguards to the Bill. Dame Esther told BBC Radio 4's Today: 'I don't need to teach the House of Lords how to do their job. They know it very well, and they know that laws are produced by the elected chamber. 'Their job is to scrutinise, to ask questions, but not to oppose. 'So yes, people who are adamantly opposed to this bill, and they have a perfect right to oppose it, will try and stop it going through the Lords, but the Lords themselves, their duty is to make sure that law is actually created by the elected chamber, which is the House of Commons who have voted this through.' Dame Esther, who turns 85 on Sunday and has terminal cancer, acknowledged the legislation would probably not become law in time for her to use it and she would have to 'buzz of to Zurich' to use the Dignitas clinic. Paralympian and crossbench peer Baroness Tanni Grey-Thompson told BBC Breakfast: 'We're getting ready for it to come to the Lord's and from my personal point of view, about amending it to make it stronger. 'We've been told it's the strongest Bill in the world, but to be honest, it's not very high bar for other legislation. 'So I do think there are a lot more safeguards that could be put in.' Conservative peer and disability rights campaigner Lord Shinkwin said the narrow Commons majority underlined the need for peers to take a close look at the legislation. He told Today 'I think the House of Lords has a duty to expose and to subject this Bill to forensic scrutiny' but 'I don't think it's a question of blocking it so much as performing our duty as a revising chamber'. He added: 'The margin yesterday was so close that many MPs would appreciate the opportunity to look at this again in respect of safeguards as they relate to those who feel vulnerable, whether that's disabled people or older people.' Labour MP Kim Leadbeater, who steered the Bill through the Commons, told the PA news agency she hoped peers would not seek to derail the legislation, which could run out of parliamentary time if it is held up in the Lords. She said: 'I would be upset to think that anybody was playing games with such an important and such an emotional issue.' A group of 27 Labour MPs who voted against the legislation said: 'We were elected to represent both of those groups and are still deeply concerned about the risks in this Bill of coercion of the old and discrimination against the disabled, people with anorexia and black, Asian and minority ethnic people, who we know do not receive equitable health care. 'As the Bill moves to the House of Lords it must receive the scrutiny that it needs. Not about the principles of assisted dying but its application in this deeply flawed Bill.' Meanwhile, one of the leading opponents of the Bill, Conservative Danny Kruger, said 'these are apocalyptic times'. In a series of tweets on Friday night, the East Wiltshire MP – who is at odds with his mother, Great British Bake Off judge Dame Prue Leith in her support for legalisation – accused assisted dying campaigners of being 'militant anti-Christians' who had failed to 'engage with the detail of the Bill'.

Scottish Sun

38 minutes ago

• Scottish Sun

Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know

Our round-up also reveals what you need to do if your GP denies you a fat jab prescription and advice if you're intending on buying them privately NATIONAL JAB SERVICE Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called 'fat jabs' will be made available to many more Brits on the NHS. Advertisement 5 From Monday, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind Credit: Getty 5 Health chiefs hope the Mounjaro rollout will turn the tide on England's obesity crisis Credit: Getty In what marks the dawn of a new era, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind. More than three million people are thought to be eligible for tirzepatide - the active drug in Mounjaro - the strongest jab on the market. Health chiefs hope it will turn the tide on England's obesity crisis which has seen rates double since the 1990s. Advertisement Injections including Ozempic and Wegovy have previously only been available for type 2 diabetes or through specialist slimming clinics. Family doctors will now be encouraged to prescribe them in a bid to get more people on the meds. Experts hope widespread use will slash work sick days and boost the economy, while reducing rates of cancer, heart disease and dementia. But demand for the drugs is already huge and NHS clinics cannot dish them out fast enough. Here is everything you need to know as the rollout begins: Advertisement What is Mounjaro and what has it been used for so far? 5 Studies found Mounjaro caused 20 per cent weight loss over 18 months Credit: Reuters FOR anyone who has missed the frenzy, Mounjaro, aka tirzepatide, is the newest weight loss injection used on the NHS. It has been around since 2022 and triggers fullness hormones in the gut to prevent hunger and over-eating. This works the same as older jabs Wegovy and Ozempic, all known as GLP-1 agonists, but a recent trial showed it is more effective. A head-to-head study in the New England Journal of Medicine found Mounjaro caused 20 per cent weight loss over 18 months, while semaglutide – the active ingredient in Wegovy and Ozempic – led to 14 per cent. Advertisement All the jabs were originally invented to treat type 2 diabetes but trials found they could also cause major weight loss. Pharma firms have cashed in on the discovery and UK prescriptions have skyrocketed. NHS prescriptions of Mounjaro in England surged from just 3,300 in 2023 to 1.1million last year, and more than a million people are estimated to be buying it online. Weight Loss Jabs - Pros vs Cons Who will be eligible in the new rollout? THE new rollout starting on Monday will allow GPs to prescribe tirzepatide for weight loss, starting with those patients whose weight places them at greatest health risk. Top of the list will be those with a body mass index (BMI) of 40 or higher and four weight-related health conditions. Advertisement A BMI of 40 is roughly equal to weighing 16st (102kg) for an average height 5'3' woman, or 19st 6lbs (123kg) for an average 5'9' man. Weight-related conditions include high cholesterol, high blood pressure, prediabetes, type 2 diabetes, obstructive sleep apnoea and heart disease. Patients will likely be expected to have tried diet and exercise first before being offered a jab. Many are likely to miss out, as some 13.5million adults in England are obese but only 3.4million are estimated to be eligible in the rollout. How will the rollout be run and what is new? 5 Wes Streeting wants a more widespread use of the drugs but patients must also receive check-ups Credit: Getty Advertisement WHAT'S new is that the rollout will be the first run by NHS primary care, led by GP surgeries. In theory this should make life easier for patients – but GPs will not be able to meet the huge demand. NHS bosses have admitted it will take a staggering 12 years to treat everyone who is eligible. Just 220,000 extra people are likely to get Mounjaro by 2028. Private prescriptions, costing about £100-£150 per month, already vastly outnumber that and are rising. Advertisement Health Secretary Wes Streeting wants a faster rollout and more widespread use of the drugs but patients must also receive regular check-ups and lifestyle help. Officials are investigating whether they can dish them out through pharmacies or the NHS app to take a load off GPs. Professor Jason Halford, of the European Association for the Study of Obesity, said: 'These drugs have the potential to help millions. 'If the government and NHS are serious about prevention they need to reconsider their position on the speed of the rollout of these drugs.' Professor John Deanfield, a heart doctor at University College London, added: 'These drugs provide a real opportunity to delay many diseases of ageing all at the same time and potentially transform society. Advertisement 'I hope it won't take 10 years to do something that is so needed.' What if my GP says no? 5 If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services Credit: Getty MANY people are expected to miss out and some surgeries are already pouring cold water on patients' hopes. Fairhill Medical Practice in Kingston upon Thames said: 'Once we are able to prescribe weight loss injections they will be offered to those with the highest medical need only, which may mean that a lot of patients will be disappointed.' Millions who meet the prescription criteria will simply have to be denied the drugs because doctors are so busy. Advertisement On top of everything else England's 6,300 doctors' surgeries have to deal with, they do not have the capacity to offer the necessary long-term supervision for millions more people at once. Experts reckon private prescriptions will rocket even more as frustrated patients give up waiting. If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services. Known as tier 2 and tier 3 weight management services, they may prescribe the jabs after other weight loss attempts. Many people are expected to find it easier to go private, with the injections widely available from high street pharmacies like Boots, Superdrug, and even Asda. Advertisement Olivier Picard, of the National Pharmacy Association, said: 'NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately.' Advice for people buying them privately BUYING the drugs online might seem like the faster fix – but buyer beware. Slimming success stories are everywhere but so, too, are tales of horror. Many patients have been duped by dodgy sellers, suffered severe side effects or even died after taking jabs they bought online. Bargain prices, easy tick-box applications, or prescriptions with no follow-up, should all be red flags to online shoppers. Advertisement Many pharmacies have been rapped for giving them away to people who do not meet the obesity criteria, potentially putting their health at risk. Dose strength is partly based on size and pretending you are fatter than you are could mean you end up with a medication too strong for your body, raising the risk of serious side effects. The most common side effects from the injections include feeling sick, vomiting, diarrhoea or other gut troubles. If not treated properly people can suffer more serious impacts like dehydration, gallstones, pancreatitis or allergic reactions – and more than 100 deaths in the UK have so far been linked to the jabs. The General Pharmaceutical Council issued new rules in February to say that all pharmacies must verify a patient's height and weight, and conduct at least a video call – if not face-to-face appointment – before prescribing weight loss injections. Advertisement Dr Emily Pegg, associate vice president at Lilly, which makes Mounjaro, said: 'This is still a prescription-only medicine, should only be prescribed by a registered healthcare professional and needs to be dispensed by a registered pharmacy. 'It is not something that people should be able to buy by just going out and going on to a social media site and clicking a button and it gets delivered to them. 'That is not appropriate and is probably illegal. 'Patient safety is a high priority.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Future of fat jabs WHILE the Mounjaro rollout is expected to kick off with a whimper and not a bang, it is hoped it will mark the beginning of a new era in weight loss medicine. Advertisement Brits have been getting gradually fatter for decades and no medication or government policy has managed to beat the bulge. The drugs appear super-effective, reasonably priced and relatively safe, and could help millions slim down after failed diets. They are expected to reduce the risks of type 2 diabetes, cancer and dementia. And studies increasingly show they improve health in other ways on top of weight loss, too, reducing the risk of heart attacks and strokes. NHS medical director, Professor Sir Stephen Powis, believes they could one day be as transformative as cholesterol-lowering statins, which have slashed heart attacks since they were rolled out decades ago. Advertisement Prof Powis said: 'I think over time it's highly likely that these drugs will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'This is very exciting – we're in the foothills of learning how to use them.'